Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
DR. REDDYS LAB TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DR. REDDYS LAB Mar-23 |
TEVA PHARMA Dec-13 |
DR. REDDYS LAB/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 4,656 | 3,477 | - | |
Low | Rs | 3,788 | 3,020 | - | |
Sales per share (Unadj.) | Rs | 1,481.4 | 1,995.2 | - | |
Earnings per share (Unadj.) | Rs | 270.7 | 124.6 | - | |
Cash flow per share (Unadj.) | Rs | 345.7 | 285.9 | - | |
Dividends per share (Unadj.) | Rs | 40.00 | 109.11 | - | |
Avg Dividend yield | % | 0.9 | 3.4 | 28.2% | |
Book value per share (Unadj.) | Rs | 1,389.6 | 2,216.3 | - | |
Shares outstanding (eoy) | m | 166.53 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.8 | 1.6 | 175.0% | |
Avg P/E ratio | x | 15.6 | 26.1 | 59.9% | |
P/CF ratio (eoy) | x | 12.2 | 11.4 | 107.5% | |
Price / Book Value ratio | x | 3.0 | 1.5 | 207.3% | |
Dividend payout | % | 14.8 | 87.5 | 16.9% | |
Avg Mkt Cap | Rs m | 703,039 | 2,754,567 | 25.5% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 46,466 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,645.0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,351.7 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 246,697 | 1,691,953 | 14.6% | |
Other income | Rs m | 10,555 | 0 | - | |
Total revenues | Rs m | 257,252 | 1,691,953 | 15.2% | |
Gross profit | Rs m | 63,860 | 463,342 | 13.8% | |
Depreciation | Rs m | 12,502 | 136,762 | 9.1% | |
Interest | Rs m | 1,428 | 33,233 | 4.3% | |
Profit before tax | Rs m | 60,485 | 293,347 | 20.6% | |
Minority Interest | Rs m | 0 | 1,333 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,566 | -0.0% | |
Tax | Rs m | 15,412 | -3,581 | -430.3% | |
Profit after tax | Rs m | 45,073 | 105,695 | 42.6% | |
Gross profit margin | % | 25.9 | 27.4 | 94.5% | |
Effective tax rate | % | 25.5 | -1.2 | -2,087.0% | |
Net profit margin | % | 18.3 | 6.2 | 292.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 203,161 | 1,142,739 | 17.8% | |
Current liabilities | Rs m | 85,721 | 996,565 | 8.6% | |
Net working cap to sales | % | 47.6 | 8.6 | 551.0% | |
Current ratio | x | 2.4 | 1.1 | 206.7% | |
Inventory Days | Days | 79 | 91 | 87.3% | |
Debtors Days | Days | 107 | 96 | 111.8% | |
Net fixed assets | Rs m | 112,638 | 552,629 | 20.4% | |
Share capital | Rs m | 833 | 4,165 | 20.0% | |
Net worth | Rs m | 231,404 | 1,879,439 | 12.3% | |
Long term debt | Rs m | 1,278 | 865,133 | 0.1% | |
Total assets | Rs m | 315,799 | 3,866,655 | 8.2% | |
Interest coverage | x | 43.4 | 9.8 | 441.2% | |
Debt to equity ratio | x | 0 | 0.5 | 1.2% | |
Sales to assets ratio | x | 0.8 | 0.4 | 178.5% | |
Return on assets | % | 14.7 | 3.6 | 409.8% | |
Return on equity | % | 19.5 | 5.6 | 346.4% | |
Return on capital | % | 26.6 | 4.9 | 539.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 58,875 | 269,610 | 21.8% | |
From Investments | Rs m | -41,373 | -95,534 | 43.3% | |
From Financial Activity | Rs m | -26,861 | -323,415 | 8.3% | |
Net Cashflow | Rs m | -9,073 | -149,339 | 6.1% |
Compare DR. REDDYS LAB With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare DR. REDDYS LAB With: PHAARMASIA KILITCH DRUGS MURAE ORGANISOR MERCURY LAB. SHILPA MEDICARE
Indian share turned positive as the session progressed and ended the day higher.